Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Blood rheology in children with the S/β+-thalassemia syndrome.

Renoux C, Joly P, Gauthier A, Pialoux V, Romanet-Faes C, Bertrand Y, Garnier N, Cuzzubbo D, Cannas G, Connes P.

Clin Hemorheol Microcirc. 2018;69(1-2):207-214. doi: 10.3233/CH-189119.

PMID:
29630544
2.

Association between Oxidative Stress, Genetic Factors, and Clinical Severity in Children with Sickle Cell Anemia.

Renoux C, Joly P, Faes C, Mury P, Eglenen B, Turkay M, Yavas G, Yalcin O, Bertrand Y, Garnier N, Cuzzubbo D, Gauthier A, Romana M, Möckesch B, Cannas G, Antoine-Jonville S, Pialoux V, Connes P.

J Pediatr. 2018 Apr;195:228-235. doi: 10.1016/j.jpeds.2017.12.021. Epub 2018 Feb 13.

PMID:
29449005
3.

Plasmapheresis may improve clinical condition in sickle cell disease through its effects on red blood cell rheology.

Nader E, Connes P, Lamarre Y, Renoux C, Joly P, Hardy-Dessources MD, Cannas G, Lemonne N, Ballas SK.

Am J Hematol. 2017 Nov;92(11):E629-E630. doi: 10.1002/ajh.24870. Epub 2017 Aug 17. No abstract available.

PMID:
28741718
4.

Hydroxycarbamine: from an Old Drug Used in Malignant Hemopathies to a Current Standard in Sickle Cell Disease.

Cannas G, Poutrel S, Thomas X.

Mediterr J Hematol Infect Dis. 2017 Feb 15;9(1):e2017015. doi: 10.4084/MJHID.2017.015. eCollection 2017. Review.

5.

Alpha-thalassaemia promotes frequent vaso-occlusive crises in children with sickle cell anaemia through haemorheological changes.

Renoux C, Connes P, Nader E, Skinner S, Faes C, Petras M, Bertrand Y, Garnier N, Cuzzubbo D, Divialle-Doumdo L, Kebaïli K, Renard C, Gauthier A, Etienne-Julan M, Cannas G, Martin C, Hardy-Dessources MD, Pialoux V, Romana M, Joly P.

Pediatr Blood Cancer. 2017 Aug;64(8). doi: 10.1002/pbc.26455. Epub 2017 Jan 18.

PMID:
28097791
6.

UGT1A1 (TA)n genotype is not the major risk factor of cholelithiasis in sickle cell disease children.

Joly P, Renoux C, Lacan P, Bertrand Y, Cannas G, Garnier N, Cuzzubbo D, Kebaïli K, Renard C, Gauthier A, Pialoux V, Martin C, Romana M, Connes P.

Eur J Haematol. 2017 Mar;98(3):296-301. doi: 10.1111/ejh.12838. Epub 2017 Jan 9.

PMID:
27981643
7.

Does calling alcoholism an illness make a difference? The public image of alcoholism in Italy.

Piras AP, Preti A, Moro MF, Giua A, Sini G, Piras M, Pintus M, Pintus E, Manca A, Cannas G, Cossu G, Angermeyer MC, Carta MG.

Drug Alcohol Depend. 2016 Sep 1;166:39-44. doi: 10.1016/j.drugalcdep.2016.06.015. Epub 2016 Jun 20.

PMID:
27373185
8.

Effect of Age on Blood Rheology in Sickle Cell Anaemia and Sickle Cell Haemoglobin C Disease: A Cross-Sectional Study.

Renoux C, Romana M, Joly P, Ferdinand S, Faes C, Lemonne N, Skinner S, Garnier N, Etienne-Julan M, Bertrand Y, Petras M, Cannas G, Divialle-Doumdo L, Nader E, Cuzzubbo D, Lamarre Y, Gauthier A, Waltz X, Kebaili K, Martin C, Hot A, Hardy-Dessources MD, Pialoux V, Connes P.

PLoS One. 2016 Jun 29;11(6):e0158182. doi: 10.1371/journal.pone.0158182. eCollection 2016.

9.

Importance of methodological standardization for the ektacytometric measures of red blood cell deformability in sickle cell anemia.

Renoux C, Parrow N, Faes C, Joly P, Hardeman M, Tisdale J, Levine M, Garnier N, Bertrand Y, Kebaili K, Cuzzubbo D, Cannas G, Martin C, Connes P.

Clin Hemorheol Microcirc. 2016;62(2):173-9. doi: 10.3233/CH-151979.

PMID:
26444610
10.

Transfusion dependency at diagnosis and transfusion intensity during initial chemotherapy are associated with poorer outcomes in adult acute myeloid leukemia.

Cannas G, Fattoum J, Raba M, Dolange H, Barday G, François M, Elhamri M, Salles G, Thomas X.

Ann Hematol. 2015 Nov;94(11):1797-806. doi: 10.1007/s00277-015-2456-2. Epub 2015 Jul 23.

PMID:
26202609
11.

Economic analysis of blood product transfusions according to the treatment of acute myeloid leukemia in the elderly.

Cannas G, Fattoum J, Boukhit M, Thomas X.

Transfus Clin Biol. 2015 Oct-Dec;22(5-6):341-7. doi: 10.1016/j.tracli.2015.06.249. Epub 2015 Jul 14.

PMID:
26184429
12.

Effect of Age on Treatment Decision-Making in Elderly Patients With Acute Myeloid Leukemia.

Fattoum J, Cannas G, Elhamri M, Tigaud I, Plesa A, Heiblig M, Plesa C, Wattel E, Thomas X.

Clin Lymphoma Myeloma Leuk. 2015 Aug;15(8):477-83. doi: 10.1016/j.clml.2015.02.022. Epub 2015 Mar 5.

PMID:
25843415
13.

Supportive care in patients with acute leukaemia: historical perspectives.

Cannas G, Thomas X.

Blood Transfus. 2015 Apr;13(2):205-20. doi: 10.2450/2014.0080-14. Epub 2014 Oct 23. Review. No abstract available.

14.

Mobilization of CD34(+)CD38(-) hematopoietic stem cells after priming in acute myeloid leukemia.

Plesa A, Chelghoum Y, Mattei E, Labussière H, Elhamri M, Cannas G, Morisset S, Tagoug I, Michallet M, Dumontet C, Thomas X.

World J Stem Cells. 2013 Oct 26;5(4):196-204. doi: 10.4252/wjsc.v5.i4.196.

15.

Impact of anti-HLA antibodies on allogeneic hematopoietic stem cell transplantation outcomes after reduced-intensity conditioning regimens.

Detrait M, Dubois V, Sobh M, Morisset S, Tedone N, Labussière H, Gillis L, Barraco F, Cannas G, Ducastelle S, Fatoum J, Thomas X, Chelgoum Y, Nicolini FE, Michallet M.

Exp Hematol. 2012 Oct;40(10):792-9. doi: 10.1016/j.exphem.2012.06.003. Epub 2012 Jun 12.

PMID:
22705505
16.

Lenalidomide in lower-risk myelodysplastic syndromes with karyotypes other than deletion 5q and refractory to erythropoiesis-stimulating agents.

Sibon D, Cannas G, Baracco F, Prebet T, Vey N, Banos A, Besson C, Corm S, Blanc M, Slama B, Perrier H, Fenaux P, Wattel E; Groupe Francophone des Myélodysplasies.

Br J Haematol. 2012 Mar;156(5):619-25. doi: 10.1111/j.1365-2141.2011.08979.x. Epub 2011 Dec 23.

PMID:
22211483
17.

Infectious complications in adult acute myeloid leukemia: analysis of the Acute Leukemia French Association-9802 prospective multicenter clinical trial.

Cannas G, Pautas C, Raffoux E, Quesnel B, de Botton S, de Revel T, Reman O, Gardin C, Elhamri M, Boissel N, Fenaux P, Michallet M, Castaigne S, Dombret H, Thomas X.

Leuk Lymphoma. 2012 Jun;53(6):1068-76. doi: 10.3109/10428194.2011.636812. Epub 2012 Jan 31.

PMID:
22145959
18.

Invasive aspergillosis: an important risk factor on the short- and long-term survival of acute myeloid leukemia (AML) patients.

Michallet M, Bénet T, Sobh M, Kraghel S, El Hamri M, Cannas G, Nicolini FE, Labussière H, Ducastelle S, Barraco F, Thomas X, Chelghoum Y, Nicolle MC, Bienvenu AL, Persat F, De Monbrison F, Picot S, Vanhems P.

Eur J Clin Microbiol Infect Dis. 2012 Jun;31(6):991-7. doi: 10.1007/s10096-011-1397-5. Epub 2011 Sep 10.

PMID:
21909650
19.

Serum 25-hydroxyvitamin D levels are associated with prognosis in hematological malignancies.

Thomas X, Chelghoum Y, Fanari N, Cannas G.

Hematology. 2011 Sep;16(5):278-83. doi: 10.1179/102453311X13085644679908.

PMID:
21902891
20.

Leukocytosis and circulating blasts in older adults with newly diagnosed acute myeloid leukemia: are they valuable factors for therapeutic decision-making?

Thomas X, Chelghoum Y, Cannas G, Elhamri M, Labussière H, Tigaud I, Ducastelle S, Nicolini F, Dumontet C, Michallet M.

Clin Lymphoma Myeloma Leuk. 2011 Aug;11(4):342-9. doi: 10.1016/j.clml.2011.06.003.

PMID:
21816372
21.

Invasive aspergillosis in patients with hematologic malignancies: incidence and description of 127 cases enrolled in a single institution prospective survey from 2004 to 2009.

Nicolle MC, Bénet T, Thiebaut A, Bienvenu AL, Voirin N, Duclos A, Sobh M, Cannas G, Thomas X, Nicolini FE, De Monbrison F, Piens MA, Picot S, Michallet M, Vanhems P.

Haematologica. 2011 Nov;96(11):1685-91. doi: 10.3324/haematol.2011.044636. Epub 2011 Jul 26.

22.

[Therapeutic alternatives to native L-asparaginase in the treatment of adult acute lymphoblastic leukemia].

Thomas X, Cannas G, Chelghoum Y, Gougounon A.

Bull Cancer. 2010 Sep;97(9):1105-17. doi: 10.1684/bdc.2010.1168. Review. French.

23.

A single dose pegfilgrastim for supporting neutrophil recovery in patients treated for high-risk acute myeloid leukemia by the EMA 2000 schedule.

Derbel O, Cannas G, Le QH, Elhamri M, Chelghoum Y, Nicolas-Virelizier E, Nicolini F, Troncy J, Barraco F, Michallet M, Thomas X.

Hematology. 2010 Jun;15(3):125-31. doi: 10.1179/102453309X12583347113654.

PMID:
20557669
24.

Leukemia stem cells and new strategies to overcome resistance to therapy.

Thomas X, Cannas G.

Curr Stem Cell Res Ther. 2010 Sep;5(3):277-86. Review.

PMID:
20528758
25.

[Special issues related to the treatment of acute leukemias in women].

Thomas X, Cannas G, Chelghoum Y.

Bull Cancer. 2010 Aug;97(8):1011-22. doi: 10.1684/bdc.2010.1109. Review. French.

26.

Clofarabine for the treatment of adult acute myeloid leukemia.

Thomas X, Raffoux E, Elhamri M, Lobe I, Cannas G, Dombret H.

Future Oncol. 2009 Oct;5(8):1197-210. doi: 10.2217/fon.09.105. Review.

PMID:
19852733
27.

Phenotypic and functional analyses of dendritic cells in patients with lymphoproliferative disease of granular lymphocytes (LDGL).

Zambello R, Berno T, Cannas G, Baesso I, Binotto G, Bonoldi E, Bevilacqua P, Miorin M, Facco M, Trentin L, Agostini C, Semenzato G.

Blood. 2005 Dec 1;106(12):3926-31. Epub 2005 Aug 9.

28.

Expression and function of KIR and natural cytotoxicity receptors in NK-type lymphoproliferative diseases of granular lymphocytes.

Zambello R, Falco M, Della Chiesa M, Trentin L, Carollo D, Castriconi R, Cannas G, Carlomagno S, Cabrelle A, Lamy T, Agostini C, Moretta A, Semenzato G, Vitale M.

Blood. 2003 Sep 1;102(5):1797-805. Epub 2003 May 15.

29.

Upregulation of CXCR1 by proliferating cells in patients with lymphoproliferative disease of granular lymphocytes.

Zambello R, Trentin L, Facco M, Carollo D, Cabrelle A, Tosoni A, Cannas G, Nicolardi L, Agostini C, Semenzato G.

Br J Haematol. 2003 Mar;120(5):765-73.

PMID:
12614207
30.

[Epidemiological findings on gastric and duodenal ulcer in the pre- and post-cimetidine era. Study of 2,119 cases].

Garau G, Faret S, Balconi V, Cannas GP, Boero A.

Minerva Dietol Gastroenterol. 1987 Jul-Sep;33(3):209-16. Italian. No abstract available.

PMID:
3670670

Supplemental Content

Loading ...
Support Center